Literature DB >> 9359739

Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales.

S L Ngui1, S O'Connell, R P Eglin, J Heptonstall, C G Teo.   

Abstract

Hepatitis B virus (HBV) infection occurred despite full passive-active immunoprophylaxis in 20 of 321 infants born to mothers seropositive for hepatitis B e antigen. In 2 (12%) of 17 infected infants, mother-infant DNA sequence mismatches were found in a segment of the HBV S gene coding for antigenic determinants of the HBV surface antigen (HBsAg) amplified from sera by polymerase chain reaction (PCR). Point substitutions occurred in codons 120, 134, and 144 of the HBsAg polypeptide in the variant sequence of 1 infant and in codon 126 in the other; all were missense mutations. Mutant sequences could not be recovered from maternal sera by PCR cloning but were selectively generated using an amplification refractory mutation system. The frequency of potential vaccine escape mutants is therefore low, and these preexist maternally as minor variants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359739     DOI: 10.1086/514133

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?

Authors:  Keisuke Hino; Ashraf A Basuni; Jacqueline Ireland; Antony Newell; Jeffrey Mphahlele; Erasmus J Smit; Siew Lin Ngui; Chong Gee Teo; William F Carman
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

2.  Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants.

Authors:  Xin Wang; Wanyan Deng; Keli Qian; Haijun Deng; Yong Huang; Zeng Tu; Ailong Huang; Quanxin Long
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-08       Impact factor: 3.267

3.  HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.

Authors:  Timothy Na Archampong; Ceejay L Boyce; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T Blackard; Awewura Kwara
Journal:  Antivir Ther       Date:  2016-05-11

Review 4.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Hepatitis B in Pregnancy.

Authors:  Tram T Tran
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

Review 6.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 7.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

8.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

9.  Hepatitis B caused by a hepatitis B surface antigen escape mutant.

Authors:  Eiji Kajiwara; Yasuhito Tanaka; Tomoko Ohashi; Kotarou Uchimura; Seizo Sadoshima; Mitsuru Kinjo; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

10.  Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay.

Authors:  Carla Osiowy
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.